Related Experiment Videos
[Malignant lymphoma: REAL classification to new WHO classification]
1First Department of Pathology, School of Medicine Fukuoka University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 31, 2000
Summary
The Revised European-American Classification of Lymphoid Neoplasms (REAL) established lymphomas as distinct entities. This paper highlights key differences between the REAL and the upcoming World Health Organization (WHO) lymphoma classifications.
Area of Science:
- Hematology
- Oncology
- Pathology
Context:
- The Revised European-American Classification of Lymphoid Neoplasms (REAL) revolutionized lymphoma classification in 1994.
- REAL emphasized distinct disease entities based on morphology, genetics, immunophenotype, and clinical presentation.
- Site of presentation was recognized as indicative of biologic distinctions.
Purpose:
- To detail the differences between the REAL classification and the new World Health Organization (WHO) classification of malignant lymphomas.
- To prepare clinicians and researchers for the upcoming WHO classification, anticipated in 2000.
Summary:
- The REAL classification defined lymphomas by a comprehensive set of features, including clinical and laboratory data.
- The new WHO classification aims to re-categorize entities from the REAL system.
- This paper focuses on the divergences between the REAL and the forthcoming WHO lymphoma classifications.
Impact:
- Facilitates understanding of evolving lymphoma taxonomy.
- Supports accurate diagnosis and treatment strategies for malignant lymphomas.
- Aids in harmonizing international lymphoma classification standards.